CML is a clonal hematopoietic stem cell disorder characterized by the t (9;22) chromosome translocation and resultant production of the constitutively activated BCR/ABL tyrosine kinase and it has been proved to be the tumor oncogene. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.